ADHD Drug Adderall in Short Supply

However, FDA notes there is no overall shortage of ADHD medications
Capsules medicine and white medicine bottles on table in drugstore with blurred background of pharmacist and pharmacy.
Capsules medicine and white medicine bottles on table in drugstore with blurred background of pharmacist and pharmacy.Adobe Stock

MONDAY, Aug. 29, 2022 (HealthDay News) -- Labor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores.

But the U.S. Food and Drug Administration noted there is no overall shortage of ADHD medications. Only Teva is reporting supply problems, FDA spokeswoman Cherie Duvall-Jones told NBC News. "Teva Pharmaceuticals, the maker for Adderall tablets, is reporting expected delays for the next two to three months," she said.

Teva attributes the delay to a labor shortage on its packaging line, which it said has been resolved. The company added that while some pharmacies may have backorders, it should be temporary. "We expect full recovery for all inventory and orders in the coming weeks, at which point we expect no disruption at the pharmacy level," spokeswoman Kelley Dougherty said in a statement, NBC News reported.

Large pharmacy chains have not seen a widespread problem: CVS said its locations were "not experiencing supply issues for Adderall and are able to fill prescriptions as received in most cases," while Walgreens said its "current supply is meeting our patient needs at this time," NBC News reported. But small pharmacies are experiencing shortages: A National Community Pharmacists Association survey conducted from July 25 through Aug. 5 showed that of about 360 independent drugstores, 64 percent had difficulty getting Adderall.

At Killingworth Family Pharmacy in Killingworth, Connecticut, owner Keith Lyke told NBC News that he has been getting patients from other drugstores who have been unable to fill their Adderall prescriptions. But generic forms from other makers have been easy enough to get, he said. "We tell them it's a different company, so it may look different," he explained.

David Goodman, M.D., an assistant professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine in Baltimore, advised patients who take Adderall to anticipate difficulty with their prescription refills and to work with their doctors and pharmacies to get alternatives.

NBC News Article

Related Stories

No stories found.